David J. Clark - 14 Nov 2022 Form 3 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role: Chief Medical Officer
Signature: /s/ Christopher Galletta, attorney-in-fact
Issuer symbol: TRVI
Transactions as of: 14 Nov 2022
Net transactions value: $0
Form type: 3
Filing time: 14 Nov 2022, 15:30:02 UTC
Next filing: 16 Feb 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney